美鼎生物 VIVO 深沪

已收盘 01-31 16:00:00 美东时间

33.97

0.000

0.00%

华盛通

立即下载

最高--
今开--
成交量 0股
最低 --
昨收 33.97
总市值 14.95亿
52周最高 34.375
市盈率 ^静 35.50
换手率 0.00%
52周最低 23.444
委比 0.00%
总股本 4400.82万
历史最高 34.375
量比 0
振幅 0.00%
历史最低 5.51
每手 1
风险率 0.00%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

AI+AR眼镜显示核心：微显和光学模组的技术和市场演进 | 钛资本研究院

文 | 钛资本研究院随着AI 与光学技术的突破，AR 眼镜正加速从产品迭代走向消费市场，AI+AR眼镜以“无感交互+空间计算”重新定义人机共生，成为下一代个...

10-27 15:34
信息直达，体验升级！极光推送助力轻喜到家重塑互联网家政服务新体验

（来源：极光JIGUANG）在家政服务行业数字化进程加速的今天，服务的标准化、透明化和可靠性成为用户选择的核心考量因素。深圳轻喜到家科技有限公司（以下简称"轻...

10-24 16:16
好买股权母基金捷报：9月，26家被投企业获后轮融资

（来源：好买臻财VIP）欢迎来到好买臻财VIP每月固定栏目好买股权母基金捷报 2025年前三季度中国股权投资市场投资聚...

10-21 17:34
阿里系营销一号位救火，极氪风评反转了

贾浩楠发自副驾寺智能车参考 | 公众号 AI4Auto Orin升级到Thor、400V变800V、激光雷达标配、电机功率900匹…… 结果么，售价比老款...

10-20 15:00
Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting

Integra LifeSciences will exhibit at the CNS Annual Meeting (Oct. 11-15, 2025, Los Angeles) showcasing new products: Durepair Dura Regeneration Matrix and Mayfield Ghost Base Unit, Post. These innovations enhance neurosurgical care with improved visualization and dural repair. The company aims to connect with experts and highlight its dedication to advancing patient outcomes. Integra’s booth (#713) will also feature other medical technologies, un...

10-08 12:30
VivoPower Closes Additional $19 Million Equity Raise Priced at $6.05 Per Share, a Premium to Market

VivoPower International PLC successfully closed an equity raise of approximately $19 million at $6.05 per share, a premium to the last market price. This raise supplements a previously announced Regulation S offering led by Prince Abdulaziz bin Turki bin Talal Al Saud. Proceeds will scale the Company's XRP digital asset treasury strategy and retire debt. VivoPower is transitioning to a digital treasury model, focusing on XRP acquisition and manag...

10-01 16:00
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device

Vivos Therapeutics发布新数据显示，其FDA认证的DNA设备能有效缓解儿童ADHD和阻塞性睡眠呼吸暂停（OSA）症状。该设备是非手术、非药物治疗中重度OSA的创新方案，临床试验显示患儿症状改善显著。

09-30 12:30
昀冢科技获评“未来产业之星上市公司”

近日，在上海国研未来产业研究院等机构联合举办的第三届中国上市公司产业发展论坛“未来产业之星”评选活动中，昀冢科技（688260.SH）获评“未来产业之星上市公司”。

09-30 08:15
VivoPower Establishes South Korean Office and Appoints Local Representative Director

VivoPower International PLC announces the establishment of a South Korean office and appoints Mr. Chris Kim as local representative director, reflecting its commitment to South Korea's strategic importance in its XRP-focused digital asset treasury strategy. Kim, a seasoned venture capitalist, brings extensive experience and local market knowledge. The company highlighted South Korea's significant XRP ownership and its potential for growth in bloc...

09-29 13:15
金九银十消费火热，转转官方验业务销售、回收齐头并进

适逢“金九银十”消费旺季，国内闲置交易持续升温。得益于官方验服务的品质保障与高效履约能力，转转二手销售及回收买卖两侧均迎来强劲增长。 9月25日，转转对外数据显...

09-26 14:48

派息除权日	每股总股息	派息日期
2019-02-01	0.13	2019-02-14
2018-11-16	0.13	2018-11-30
2018-08-09	0.13	2018-08-20
2018-05-04	0.13	2018-05-17
2018-02-02	0.13	2018-02-15
2017-11-17	0.13	2017-11-30
2017-08-03	0.13	2017-08-17
2017-05-04	0.13	2017-05-18
2017-02-02	0.13	2017-02-16
2016-11-17	0.20	2016-12-01
2016-08-04	0.20	2016-08-18
2016-05-05	0.20	2016-05-19
2016-02-04	0.20	2016-02-18
2015-11-12	0.20	2015-11-27
2015-07-30	0.20	2015-08-13
2015-04-30	0.20	2015-05-14
2015-01-29	0.20	2015-02-13
2014-11-13	0.20	2014-11-28
2014-07-31	0.20	2014-08-14
2014-05-01	0.20	2014-05-15
2014-01-30	0.20	2014-02-14
2013-11-14	0.19	2013-11-29
2013-08-01	0.19	2013-08-15
2013-05-01	0.19	2013-05-14
2012-12-12	0.19	2012-12-24
2012-11-15	0.19	2012-11-30
2012-08-02	0.19	2012-08-16
2012-05-02	0.19	2012-05-14
2012-02-01	0.19	2012-02-17
2011-11-17	0.19	2011-12-01
2011-07-28	0.19	2011-08-11
2011-04-28	0.19	2011-05-12
2011-01-27	0.19	2011-02-10
2010-11-18	0.19	2010-12-03
2010-07-27	0.19	2010-08-09
2010-04-27	0.19	2010-05-10
2010-01-28	0.19	2010-02-11
2009-11-19	0.17	2009-12-03
2009-07-23	0.17	2009-08-07
2009-04-22	0.17	2009-05-05
2009-01-29	0.17	2009-02-09
2008-11-19	0.14	2008-12-02
2008-07-28	0.14	2008-08-07
2008-04-24	0.14	2008-05-05
2008-01-29	0.14	2008-02-07
2007-11-21	0.11	2007-12-03
2007-07-26	0.11	2007-08-06
2007-04-26	0.16	2007-05-07
2007-01-25	0.16	2007-02-05
2006-11-22	0.12	2006-12-04
2006-07-27	0.12	2006-08-07
2006-04-27	0.12	2006-05-08
2006-01-30	0.12	2006-02-09
2005-11-17	0.08	2005-12-01
2005-08-02	0.12	2005-08-08
2005-04-28	0.12	2005-05-09
2005-01-28	0.12	2005-02-08
2004-11-23	0.10	2004-12-06
2004-07-29	0.10	2004-08-09
2004-04-29	0.10	2004-05-10
2004-01-29	0.10	2004-02-09
2003-11-25	0.09	2003-12-05
2003-07-30	0.09	2003-08-08
2003-04-29	0.09	2003-05-09
2003-01-30	0.09	2003-02-10
2002-11-21	0.07	2002-12-03
2002-07-31	0.07	2002-08-09
2002-04-29	0.07	2002-05-09
2002-01-30	0.07	2002-02-07
2001-11-21	0.06	2001-12-04
2001-07-30	0.06	2001-08-09
2001-04-27	0.06	2001-05-09
2001-01-30	0.06	2001-02-08
2000-11-22	0.06	2000-12-05
2000-07-28	0.06	2000-08-08
2000-04-27	0.06	2000-05-09
2000-01-28	0.06	2000-02-08
1999-11-22	0.05	1999-12-07
1999-07-29	0.05	1999-08-10
1999-04-29	0.05	1999-05-11
1999-01-28	0.05	1999-02-09
1998-11-23	0.05	1998-12-08
1998-08-03	0.05	1998-08-18
1998-04-29	0.05	1998-05-12
1998-01-28	0.05	1998-02-09
1997-11-25	0.07	1997-12-08
1997-07-30	0.04	1997-08-11
1997-04-30	0.04	1997-05-12
1997-01-30	0.04	1997-02-11
1996-11-25	0.06	1996-12-06
1996-08-01	0.04	1996-08-13
1996-04-23	0.04	1996-05-03
1996-02-01	0.04	1996-02-12
1995-11-21	0.03	1995-12-01
1995-08-02	0.04	1995-08-14
1995-05-02	0.04	1995-05-16
1995-01-30	0.04	1995-02-09
1994-11-08	0.03	1994-11-22
1994-08-05	0.03	1994-08-18
1994-05-10	0.03	1994-05-23
1994-02-24	0.03	1994-03-08
1993-11-24	0.03	1993-12-08
1993-08-05	0.03	1993-08-18
1993-05-04	0.03	1993-05-17
1993-02-23	0.03	1993-03-09
1992-11-17	0.02	1992-12-01
1992-08-07	0.02	1992-08-20
1992-05-04	0.02	1992-05-15
1992-02-24	0.03	1992-03-06
1991-12-09	0.02	1991-12-20
1991-08-13	0.02	1991-08-26
1991-05-08	0.02	1991-05-21
1991-02-25	0.02	1991-03-11
1990-11-29	0.06	1990-12-20

公司名称	美鼎生物
行业分类	医疗设备
业务描述	Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. Its platforms include molecular, immunoassay, urea breath, and blood chemistry. It operates through the Diagnostics and Life Science segments. The Diagnostics segment consists of manufacturing operations for infectious disease and blood chemistry products and the sale and distribution of diagnostics products domestically and abroad. The Life Science segment distributes bulk antigens, antibodies, polymerase chain reaction/ quantitative PCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.

美鼎生物 VIVO 深 沪

33.97

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

美鼎生物 VIVO 深沪